文献速递细菌感染、耐药与抗菌药物医院感染防控

实体器官移植后诺卡菌病的结局与治疗:欧洲研究新见解

Outcome and Treatment of Nocardiosis After Solid Organ Transplantation: New Insights From a European Study.
PubMed 文献 · Clin Infect Dis · 2017-01-01

该欧洲多中心病例对照研究纳入2000–2014年诊断的117例实体器官移植后诺卡菌病患者,发现1年死亡率16.2%,为对照移植受者(1.3%)的10倍;肿瘤史、侵袭性真菌感染和供体年龄与1年死亡率独立相关,而诺卡菌病前一年内急性排斥与生存改善相关。17例接受短疗程抗生素(中位56天)的患者1年成功率达88%,复发风险5.9%。

要点

  • 实体器官移植后诺卡菌病1年死亡率为16.2%,显著高于对照移植受者的1.3%。
  • 肿瘤史、侵袭性真菌感染和供体年龄是与1年死亡率独立相关的因素。
  • 短疗程抗生素(≤120天)治疗者1年成功率达88%,复发风险5.9%。

核心结论

  • 实体器官移植后诺卡菌病患者1年死亡率较无诺卡菌病的对照移植受者高10倍。
  • 四个因素(主要反映一般医疗状况而非诺卡菌病严重程度和管理)与1年死亡率独立相关。
  • 接受短疗程抗生素治疗的患者结局良好,提示该策略值得进一步研究。

研究设计与样本

  • 欧洲多中心病例对照研究,纳入2000–2014年诊断的117例实体器官移植后诺卡菌病患者。
  • 采用多变量条件logistic回归识别与1年全因死亡率相关的因素。

主要发现

  • 诺卡菌病患者1年死亡率为16.2%(19/117),对照移植受者为1.3%(3/233),P < .001。
  • 肿瘤史(OR 1.4;95% CI 1.1-1.8)、侵袭性真菌感染(OR 1.3;95% CI 1.1-1.5)和供体年龄(OR 1.0046;95% CI 1.0007-1.0083)与1年死亡率独立相关。
  • 诺卡菌病前一年内急性排斥与生存改善相关(OR 0.85;95% CI 0.73-0.98)。
  • 17例接受短疗程抗生素(中位56天,范围24-120天)的患者1年成功率(治愈且存活)为88%,复发风险5.9%(中位随访49个月,范围6-136个月)。

临床怎么用

  • 实体器官移植后诺卡菌病患者应评估肿瘤史、侵袭性真菌感染和供体年龄等与1年死亡率相关的因素。
  • 短疗程抗生素(≤120天)可作为进一步研究的治疗策略,但需注意复发监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Solid organ transplant (SOT) recipients are at risk of nocardiosis, a rare opportunistic bacterial infection, but prognosis and outcome of these patients are poorly defined. Our objectives were to identify factors associated with 1-year mortality after nocardiosis and describe the outcome of patients receiving short-course antibiotics (≤120 days). METHODS: We analyzed data from a multicenter European case-control study that included 117 SOT recipients with nocardiosis diagnosed between 2000 and 2014. Factors associated with 1-year all-cause mortality were identified using multivariable conditional logistic regression. RESULTS: One-year mortality was 10-fold higher in patients with nocardiosis (16.2%, 19/117) than in control transplant recipients (1.3%, 3/233, P < .001). A history of tumor (odds ratio [OR], 1.4; 95% confidence interval [CI], 1.1-1.8), invasive fungal infection (OR, 1.3; 95% CI, 1.1-1.5), and donor age (OR, 1.0046; 95% CI, 1.0007-1.0083) were independently associated with 1-year mortality. Acute rejection in the year before nocardiosis was associated with improved survival (OR, 0.85; 95% CI, 0.73-0.98). Seventeen patients received short-course antibiotics (median duration 56 [24-120] days) with a 1-year success rate (cured and surviving) of 88% and a 5.9% risk of relapse (median follow-up 49 [6-136] months). CONCLUSIONS: One-year mortality was 10-fold higher in SOT patients with nocardiosis than in those without. Four factors, largely reflecting general medical condition rather than severity and/or management of nocardiosis, were independently associated with 1-year mortality. Patients who received short-course antibiotic treatment had good outcomes, suggesting that this may be a strategy for further study.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Lebeaux D, Freund R, van Delden C, et al. Outcome and Treatment of Nocardiosis After Solid Organ Transplantation: New Insights From a European Study. Clin Infect Dis. 2017. PMID: 28329348. doi:10.1093/cid/cix124

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。